aTyr Pharma | LIFE - Loan Capital


aTyr Pharma reported $12.51M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Alterity Therapeutics Limited AUD 43.68K 59.53K Dec/2025
Ardelyx USD 202.83M 696K Dec/2025
aTyr Pharma USD 12.51M 12.11M Dec/2025
Biogen USD 6.29B 1.4M Sep/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Cipla INR 2.98B 454.6M Sep/2025
Clal Biotechnology ILS 25.96M 18.48M Dec/2023
Compugen USD 0 0 Dec/2024
CSL USD 10.42B 273M Dec/2025
Curis USD 29.43M 10.69M Jun/2024
Galapagos EUR 5.19M 574K Dec/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
Grifols EUR 9.95B 722.93M Dec/2025
Novartis USD 29.59B 5.35B Dec/2025
Roche Holding CHF 27.43B 966M Dec/2025
United Therapeutics USD 100M 100M Jun/2024
Xoma USD 94.38M 7.82M Sep/2025